A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1325 participants.
Also called NCT07361302
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,325 participants
- Sponsor
- Registry
-
NCT07361302 -
2025-522542-40-00 -
U1111-1323-6001
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Argentina, Australia, Bulgaria, China, Greece, Hungary, India, Indonesia, Kazakhstan, Malaysia, Norway, Romania, Spain, Taiwan, Thailand, Vietnam
- Registry status
- Recruiting
Technical summary
Registry record NCT07361302. Randomized; no masking; primary purpose treatment. Start 2026-02-17 (actual); primary completion 2027-10-02 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well
- Acronym
- TENACITY
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- Tenecteplase
- Intervention (Drug)
- Standard of care treatment
- Lead sponsor
- Boehringer Ingelheim
Record details
- Record id
cardio:ct-nct07361302- Content hash
d2f8451ebf7bab1b89e002cc98ffd9c2febd591f97c78800e42a4873a6e9eb0b